LIPOCALIN-PROSTAGLANDIN D SYNTHASE IS A CRITICAL BENEFICIAL FACTOR IN TRANSIENT AND PERMANENT FOCAL CEREBRAL ISCHEMIA
LIPOCALIN-PROSTAGLANDIN D SYNTHASE IS A CRITICAL BENEFICIAL FACTOR IN TRANSIENT AND PERMANENT FOCAL CEREBRAL ISCHEMIA
复制标题
DOI:
10.1016/j.neuroscience.2009.02.039
复制
发表时间:
2009-04-21
期刊:
影响因子:
3.3
通讯作者:
Dore, S.
中科院分区:
文献类型:
--
作者:
Saleem, S.;Shah, Z. A.;Dore, S.
Prostaglandin D-2 (PGD(2)) is the most abundant prostaglandin produced in the brain. It is a metabolite of arachidonic acid and synthesized by prostaglandin D-2 synthases (PGDS) via the cyclooxygenase pathway. Two distinct types of PGDS have been identified: hematopoietic prostaglandin D synthase (H-PGDS) and lipocalin-type prostaglandin D synthase (L-PGDS). Because relatively little is known about the role of L-PGDS in the CNS, here we examined the outcomes in L-PGDS knockout and wild-type (WT) mice after two different cerebral ischemia models, transient middle cerebral artery (MCA) occlusion (tMCAO) and permanent distal middle cerebral artery occlusion (pMCAO). In the tMCAO model, the MCA was occluded with a monofilament for 90 min and then reperfused for 4 days. In the pMCAO model, the distal part of the MCA was permanently occluded and the mice were sacrificed after 7 days. Percent corrected infarct volume and neurological score were determined after 4 and 7 days, respectively. L-PGDS knockout mice had significantly greater infarct volume and brain edema than did WT mice after tMCAO (P